Asianet Newsable on MSN
Atossa Therapeutics stock jumps after FDA grants rare pediatric status to DMD drug — retail bets on phase 3 fast-track
The FDA’s designation broadens Atossa’s development pathway in DMD and could make the program eligible for a Priority Review ...
The FDA has approved Linzess (linaclotide) for treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older.
Ernesto Cesar Torres, 74, was convicted of sexually abusing an 11-year-old patient and prosecutors say dozens more victims ...
UPMC Children’s Community Pediatrics is seeing the flu, specifically influenza B this week. They’re also see viral upper ...
Rainbow Children’s Hospital opens a specialized centre in Chennai for advanced paediatric gut and liver care, addressing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback